Oral Oncology
Volume 38, Issue 7 , Pages 686-690 , October 2002

A Phase II trial of docetaxel and cisplatin in patients with recurrent or metastatic nasopharyngeal carcinoma

  • J.S McCarthy

      Affiliations

    • Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9
    • ,
  • I.F Tannock

      Affiliations

    • Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9
    • ,
  • P Degendorfer

      Affiliations

    • Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9
    • ,
  • T Panzarella

      Affiliations

    • Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9
    • ,
  • M Furlan

      Affiliations

    • Aventis Pharma, 2150 St. Elzear Blvd. West, Laval, Quebec, Canada H7L 4A8
    • ,
  • L.L Siu

      Affiliations

    • Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9
    • Corresponding Author InformationCorresponding author

Received 28 September 2001 ,Accepted 9 December 2001.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1368-8375(01)00134-8

Oral Oncology
Volume 38, Issue 7 , Pages 686-690 , October 2002

Article Tools

* Image Usage & Resolution